Author： Taft David
Publisher： Informa Healthcare
ISSN： 0363-9045
Source： Drug Development and Industrial Pharmacy, Vol.33, Iss.11, 2007-11, pp. : 1285-1285
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeting Mcl-1 for the therapy of cancer
By Quinn Bridget A Dash Rupesh Azab Belal Sarkar Siddik Das Swadesh K Kumar Sachin Oyesanya Regina A Dasgupta Santanu Dent Paul Grant Steven Rahmani Mohamed Curiel David T Dmitriev Igor Hedvat Michael Wei Jun Wu Bainan Stebbins John L Reed John C Pellecchia Maurizio Sarkar Devanand Fisher Paul B
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. :
Access to resources
Recommend
Downregulating sphingosine kinase-1 for cancer therapy
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. :
The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. :